Holen Sie sich die Stockscreener-App
1.98
1.98%
-0.04
Handel nachbörslich:
1.96
-0.02
-1.01%
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Screener Results Flag Vor Biopharma Inc. as OversoldRate Hike & Target Return Focused Picks - newsyoung.net
Technical Charts Suggest Momentum Shift in Vor Biopharma Inc.July 2025 Selloffs & Stock Timing and Entry Methods - newsyoung.net
Vor Biopharma: HC Wainwright Raises Buy Rating to $3, PT Raised to $3. - AInvest
Vor Biopharma's Unexpected Resurrection: A New Direction Amid Uncertainty. - AInvest
Vor Biopharma: Chinese Win Sets The Direction, But There Is Still Much Uncertainty - Seeking Alpha
Health Care Stocks Climb As Deals And Results Grab Attention - Finimize
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate - Benzinga
Vor Biopharma Skyrockets 19.72%—What’s Fueling This Biotech Breakout? - AInvest
Is Vor Bio Stock Soaring Too High? - StocksToTrade
Vor Bio, RemeGen succeed in trial for telitacicept in China - Seeking Alpha
Vor Biopharma Shares Jump After Phase 3 Telitacicept Study Achieves Primary Endpoint - MarketScreener
Surge in Vor Bio Stock: What’s Driving It? - timothysykes.com
Private Equity Firms Are Vor Biopharma Inc.'s (NASDAQ:VOR) Biggest Owners and Were Hit After Market Cap Dropped US$66m - 富途牛牛
Breakthrough for Sjögren's Disease: Vor Bio's Drug Shows Best-in-Disease Potential in Phase 3 - Stock Titan
Vor Biopharma Soars 9.04% on Bullish Analyst Forecast - AInvest
Vor Biopharma's High-Stakes Gamble: Can Telitacicept Justify the Burn? - AInvest
Borrow Rate Hikes Hit Vor Biopharma, Upexi, and Defiance 1.75x MSTR ETF Amid Market Volatility - AInvest
Is Vor Biopharma Inc. a strong growth stockBest Picks for Fast Turnaround - news-j.co.kr
Vor Biopharma VOR 2025Q2 Earnings Preview Upside Ahead on New Navigational Systems Integration - AInvest
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Update - MarketBeat
Vor Biopharma Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView
Intraday Charts Show Spike in Vor Biopharma Inc. ActivitySwing Trade Plans Emphasize Risk Management - metal.it
Vor Bio appoints seasoned biotech executive Dallan Murray as Chief Commercial Officer - MarketScreener
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer - GlobeNewswire
Vor Bio Taps Commercial Powerhouse Behind Sarepta's $1.8B Revenue Surge for Global Drug Launch - Stock Titan
What are Vor Biopharma Inc. company’s key revenue driversDynamic investment opportunities - Jammu Links News
How volatile is Vor Biopharma Inc. stock compared to the marketBuild a portfolio with strong long-term growth - Jammu Links News
What institutional investors are buying Vor Biopharma Inc. stockAchieve breakthrough investment performance - Jammu Links News
Why is Vor Biopharma Inc. stock attracting strong analyst attentionBuild wealth faster with expert stock picks - Jammu Links News
What catalysts could drive Vor Biopharma Inc. stock higher in 2025Navigate market volatility with smart strategies - Jammu Links News
What drives Vor Biopharma Inc. stock priceInvest smarter with expert trading signals - Jammu Links News
How does Vor Biopharma Inc. generate profit in a changing economyHigh-impact stock picks - Jammu Links News
What analysts say about Vor Biopharma Inc. stockRapid-fire capital growth - Jammu Links News
What makes Vor Biopharma Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News
Is Vor Biopharma Inc. stock overvalued or undervaluedSignificant capital appreciation - Jammu Links News
How many analysts rate Vor Biopharma Inc. as a “Buy”Capitalize on fast-moving trading opportunities - Jammu Links News
What are the technical indicators suggesting about Vor Biopharma Inc.Rapid wealth creation - Jammu Links News
VOR SEC FilingsVor Biopharma Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Vor Biopharma Inc. stock attracts strong analyst attentionSwing Trading Plan With Smart Signals in Review - metal.it
Insiders the biggest winners as Vor Biopharma Inc.'s (NASDAQ:VOR) market cap rises to US$302m - simplywall.st
When is Vor Biopharma Inc. stock expected to show significant growth - jammulinksnews.com
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board - MSN
These 10 Stocks are Winning Big - Insider Monkey
Vor Biopharma Shares Soar After Strategic Appointments in Leadership - StocksToTrade
Published on: 2025-07-28 13:58:09 - metal.it
What are analysts’ price targets for Vor Biopharma Inc. in the next 12 monthsGet timely alerts on market opportunities - Jammu Links News
Should I hold or sell Vor Biopharma Inc. stock in 2025Achieve breakthrough financial results - jammulinksnews.com
Does Vor Biopharma Inc. stock perform well during market downturnsMaximize your portfolio’s growth potential - Jammu Links News
What markets is Vor Biopharma Inc. expanding into Is DMAC stock a good long term investment option - jammulinksnews.com
What are the latest earnings results for Vor Biopharma Inc.Unlock real-time stock alerts for quick profits - Jammu Links News
How Efficient Is Vor Biopharma Inc. at Controlling Operating CostsDefensive Stock Picks with Upside - metal.it
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):